Enlarge / Packaging for Wegovy, manufactured by Novo Nordisk, is seen in this illustration photo. (credit: Getty | Jakub Porzycki)

With the debut of remarkably effective weight-loss drugs, America's high obesity rate and its uniquely astronomical prescription drug pricing appear to be set on a catastrophic collision course—one that threatens to "bankrupt our entire health care system," according to a new Senate report that modeled the economic impact of the drugs in different uptake scenarios.

If just half of the adults in the US with obesity start taking a new weight-loss drug, such as Wegovy, the collective cost would total an estimated $411 billion per year, the analysis found. That's more than the $406 billion Americans spent in 2022 on all prescription drugs combined.

While the bulk of the spending on weight-loss drugs will occur in the commercial market—which could easily lead to spikes in health insurance premiums—taxpayer-funded Medicare and Medicaid programs will also see an extraordinary financial burden. In the scenario that half of adults with obesity go on the drug, the cost to those federal programs would total $166 billion per year, rivaling the programs' total 2022 drug costs of $175 billion.

Enlarge / 60 Starlink satellites stacked for launch at SpaceX facility in Cape Canaveral, Florida in 2019. (credit: SpaceX)

According to the research firm Quilty Space, SpaceX's Starlink satellite Internet business is now profitable.

During a webinar on Thursday, analysts from the firm outlined the reasons why they think SpaceX has been able to achieve a positive cash flow in its space Internet business just five years after the first batch of 60 satellites were launched.

The co-founder of the firm, Chris Quilty, said the rapidity of Starlink's rise surprised a lot of people, including himself. "A lot of industry veterans kind of scoffed at the idea," he said. "We'd seen this before."

Enlarge (credit: Apu Gomes / Stringer | Getty Images News)

US District Judge William Alsup has dismissed Elon Musk's X Corp lawsuit against Bright Data, a data-scraping company accused of improperly accessing X (formerly Twitter) systems and violating both X terms and state laws when scraping and selling data.

X sued Bright Data to stop the company from scraping and selling X data to academic institutes and businesses, including Fortune 500 companies.

According to Alsup, X failed to state a claim while arguing that companies like Bright Data should have to pay X to access public data posted by X users.

Enlarge / New energy vehicles are being loaded into containers for export at Taicang Port and Taicang International Terminal in Suzhou, Jiangsu Province, China, on April 26, 2024. (credit: Photo by Costfoto/NurPhoto via Getty Images)

President Joe Biden is expected to levy new 100 percent tariffs targeted at specific Chinese industries, including electric vehicles, on Tuesday. The announcement follows growing calls from automakers, unions, and bipartisan efforts in Congress to address the problem of China unfairly subsidizing its own industries to undermine foreign competitors.

Why are Chinese EVs so cheap?

The Chinese government has been giving its green industries heavy direct subsidies for some time now, far in excess of those handed out by US or European governments. For EV makers like BYD, this has meant billions of dollars a year, in addition to the consumer-facing tax benefit for car buyers, similar to how EV sales are incentivized in the US.

Brands like BYD have concentrated on making their cars cheaper to build—only using one windshield wiper instead of two, for example—but also through vertical integration. Other than Tesla, automakers in the US, Europe, Japan, and Korea instead rely heavily on multiple tiers of suppliers, most of whom supply parts to more than one automaker.

Enlarge (credit: Getty Images | NurPhoto)

Two weeks ago, Tesla CEO Elon Musk enacted widespread layoffs throughout the company, including the 500-strong team responsible for the brand's Supercharger. Now, Tesla is looking to hire some of them back, Bloomberg reports, as Musk promises to spend $500 million expanding the network.

The Supercharger network is inarguably Tesla's crown jewel. The company recognized early on that, even though its owners slow-charged at home each night, knowing they had the ability to rapidly recharge on the road was critical in making an electric vehicle an acceptable alternative to existing vehicles.

Since then, it has built out more than 2,000 charging stations in the US alone, with more than 25,000 plugs. More than that, the chargers invariably work, something that is often not true for other charging networks.

Enlarge (credit: Getty)

A study analyzing Apple, Microsoft, and SpaceX suggests that return to office (RTO) mandates can lead to a higher rate of employees, especially senior-level ones, leaving the company, often to work at competitors.

The study (PDF), published this month by University of Chicago and University of Michigan researchers and reported by The Washington Post on Sunday, says:

In this paper, we provide causal evidence that RTO mandates at three large tech companies—Microsoft, SpaceX, and Apple—had a negative effect on the tenure and seniority of their respective workforce. In particular, we find the strongest negative effects at the top of the respective distributions, implying a more pronounced exodus of relatively senior personnel.

The study looked at résumé data from People Data Labs and used "260 million résumés matched to company data." It only examined three companies, but the report's authors noted that Apple, Microsoft, and SpaceX represent 30 percent of the tech industry's revenue and over 2 percent of the technology industry's workforce. The three companies have also been influential in setting RTO standards beyond their own companies. Robert Ployhart, a professor of business administration and management at the University of South Carolina and scholar at the Academy of Management, told the Post that despite the study being limited to three companies, its conclusions are a broader reflection of the effects of RTO policies in the US.